Eleonora Teplinsky, MD

Healio | HemOnc Today is excited to announce the nominees for its annual Disruptive Innovators Awards in oncology and hematology.

SAN ANTONIO — A randomized phase 3 clinical trial designed to assess whether circulating tumor DNA surveillance could be used to help prevent breast cancer recurrence closed early due to a lack of patients eligible for randomization.

SAN ANTONIO — Certain patients with low-risk ductal carcinoma can safely opt for active monitoring, according to study results presented at San Antonio Breast Cancer Symposium.

Every October, there are pink ribbons everywhere for breast cancer awareness month.

Healio spoke with Eleonora Teplinsky, MD, about the importance of ackowledging breast cancer awareness year-round.

Healio spoke with Eleonora Teplinsky, MD, about barriers to breast cancer care.

Healio spoke with Eleonora Teplinsky, MD, about metastatic breast cancer and other challenging subtypes of breast cancer.

Healio spoke with Eleonora Teplinsky, MD, about research on circulating tumor DNA in breast cancer.

Healio spoke with Eleonora Teplinsky, MD, about new treatment options available to patients with breast cancer.

Addressing medical misinformation and discussing new data with patients and fellow health care providers across social media platforms has become a calling for Eleonora Teplinsky, MD.